Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention.

Autor: Choo EH; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Moon D; Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Cardiology, Department of Internal Medicine, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Choi IJ; Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. mrfasthand@catholic.ac.kr.; Division of Cardiology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-dong, Bupyeong-gu, 21431, Incheon, Seoul, Republic of Korea. mrfasthand@catholic.ac.kr., Lim S; Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. mdsungminlim@gmail.com.; Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, 11765, Uijeongbu-si, Seoul, Gyeonggi-do, Republic of Korea. mdsungminlim@gmail.com., Lee J; Data Science Team, Hanmi Pharm. Co., Ltd, Seoul, Republic of Korea., Kang D; Data Science Team, Hanmi Pharm. Co., Ltd, Seoul, Republic of Korea., Hwang BH; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim CJ; Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, 11765, Uijeongbu-si, Seoul, Gyeonggi-do, Republic of Korea., Lee JM; Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, 11765, Uijeongbu-si, Seoul, Gyeonggi-do, Republic of Korea., Yoo KD; Division of Cardiology, Department of Internal Medicine, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jeon DS; Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Chang K; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Nov 05; Vol. 23 (1), pp. 396. Date of Electronic Publication: 2024 Nov 05.

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

Autor: Kim NH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea., Lee J; Department of Biostatistics, Korea University College of Medicine, Seoul, Korea., Chon S; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, Korea., Yu JM; Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea., Jeong IK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea., Lim S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Kim WJ; Division of Endocrinology, Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea., Song K; Division of Endocrinology and Metabolism, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea., Cho HC; Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea., Yu HM; Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University, Daejeon, Korea., Kim KA; Division of Endocrinology and Metabolism, Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea., Kim SS; Department of Internal Medicine, Pusan National University Hospital, Busan, Korea., Lee SH; Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea., Kim CH; Department of Internal Medicine, Bucheon Sejong Hospital, Bucheon, Korea., Kwak SH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea., Lee YH; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea., Chung CH; Department of Internal Medicine, Research Institute of Metabolism and Inflammation, Yonsei University Wonju College of Medicine, Wonju, Korea., Lee S; Department of Internal Medicine, Gachon University College of Medicine, Incheon, Korea., Jin HY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University Medical School-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea., Lee JH; Division of Endocrinology, Department of Internal Medicine, Myongji Hospital, Goyang, Korea., Koh G; Division of Endocrinology and Metabolism, Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Korea., Kim SY; Division of Endocrinology and Metabolism, Chosun University College of Medicine, Gwangju, Korea., Kim J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea., Lee JH; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea., Kim TN; Department of Internal Medicine, Inje University College of Medicine, Busan, Korea., Jeon HJ; Department of Endocrinology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea., Lee JH; Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea., Jeon JH; Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea., Yoo HJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea., Kim HK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea., Park HK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea., Nam-Goong IS; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Hong S; Department of Endocrinology and Metabolism, Inha University College of Medicine, Incheon, Korea., Ahn CW; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Yu JH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea., Park JH; Big Data Steering Department, National Health Insurance Service, Wonju, Korea., Park KG; Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea., Park CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Dong-A University Medical Center, Dong-A University College of Medicine, Busan, Korea., Joung KH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea., Ryu OH; Division of Endocrinology and Metabolism, College of Medicine, Hallym University, Chuncheon, Korea., Park KY; Department of Endocrinology and Metabolism, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea., Hong EG; Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea., Cha BS; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea., Won KC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Chung YS; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea., Kim SG; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

Publikováno v: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Oct; Vol. 39 (5), pp. 722-731. Date of Electronic Publication: 2024 Aug 22.

Analytical method development and validation for simultaneous estimation of Bempedoic acid and Ezetimibe in pure and its pharmaceutical dosage form by RP-HPLC.

Autor: Suresh A; Department of Pharmaceutical Analysis, JKKMMRFs-Annai JKK Sampoorani Ammal College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Namakkal, Tamil Nadu, India., Balakrishnan A; Department of Pharmaceutical Analysis, JKKMMRFs-Annai JKK Sampoorani Ammal College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Namakkal, Tamil Nadu, India., Ramaswamy V; Department of Pharmaceutical Analysis, JKKMMRFs-Annai JKK Sampoorani Ammal College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Namakkal, Tamil Nadu, India., Natesan S; Department of Pharmaceutical Analysis, JKKMMRFs-Annai JKK Sampoorani Ammal College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Namakkal, Tamil Nadu, India.

Publikováno v: Biomedical chromatography : BMC [Biomed Chromatogr] 2024 Sep; Vol. 38 (9), pp. e5938. Date of Electronic Publication: 2024 Jun 26.

Potential impact of ezetimibe on patients with NAFLD/NASH: a meta-analysis of randomized controlled trials.

Autor: Jiao B; Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, Liaoning, China., Wang B; Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, Liaoning, China., Liu B; Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, Liaoning, China., Zhao J; Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, Liaoning, China., Zhang Y; Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, Liaoning, China.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Oct 08; Vol. 15, pp. 1468476. Date of Electronic Publication: 2024 Oct 08 (Print Publication: 2024).

Ezetimibe protects against Gentamycin-induced ototoxicity in rats by antioxidants, anti-inflammatory mechanisms, and BDNF upregulation.

Autor: Abd-Elhafiz HI; Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt., Faried MA; Anatomy and Embryology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt., Khodir SA; Medical Physiology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt., Moaty AS; Otolaryngology department, Faculty of Medicine, Menoufia University, Menoufia, Egypt., Sweed EM; Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.

Publikováno v: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2024 Oct; Vol. 46 (5), pp. 635-650. Date of Electronic Publication: 2024 Aug 13.